Vai alla homepage
820К+ pazienti hanno ricevuto assistenza dal 2014
50 paesi
1,500 cliniche
6K+ recensioni
3K+ Oltre 3.000 medici qualificati

Qual è il costo delle procedure diagnostiche e dei trattamenti per Glioma in Italia? Scoprilo ora

Il prezzo medio per la diagnosi e il trattamento di Glioma in Italia è di $45,521, il prezzo minimo è $45,521 e il massimo è $45,521.
ItaliaTurchiaAustria
Radioterapia per il cancro colorettaleda $7,000da $7,000da $12,000
Radiochirurgia stereotassicada $25,000da $4,500da $17,000
Craniotomiada $25,000da $5,650da $20,000
Coltello Gammada $30,000da $6,300da $32,000
Chemioterapia per carcinoma mammarioda $4,500da $1,200da $15,000
Dati verificati da Bookimed a July 2026, basati sulle richieste dei pazienti e sulle offerte ufficiali di 95 cliniche in tutto il mondo. I costi mediani si basano su fatture reali (2025–2026) e sono aggiornati mensilmente. I prezzi effettivi possono variare.

I tuoi benefici e le tue garanzie con Bookimed

Prezzi diretti

Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Glioma. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.

Solo cliniche e medici verificati

Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Glioma e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.

Assistenza gratuita 24/7

Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Glioma.

Perché noi?

Il tuo coordinatore medico Bookimed personale

  • Ti supporta in ogni fase
  • Aiuta a scegliere la clinica e il medico giusti
  • Garantisce un accesso rapido e semplice alle informazioni

Scopri le migliori cliniche per il trattamento di Glioma in Italia: 3 opzioni verificate e Prezzi

Le classifiche delle cliniche di Bookimed si basano su algoritmi di data science, offrendo un confronto affidabile, trasparente e oggettivo. Considerano la richiesta dei pazienti, i punteggi delle recensioni (positive e negative), la frequenza di aggiornamento di trattamenti e prezzi, la rapidità di risposta e le certificazioni delle cliniche.
San Donato Hospital
San Raffaele

Condividi contenuto

Storie in video dei pazienti Bookimed

Dayana
I combined my vacation in Antalya with a check-up.
Procedura: Check-up femminile
Igor
It was great! Transfers, accommodation, treatment—all included.
Procedura: Impianto Dentale
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Procedura: Check-up femminile
Aggiornato: 02/06/2024
Scritto da
Anna Leonova
Anna Leonova
Responsabile del Team Content Marketing
Copywriter medico certificato con oltre 10 anni di esperienza, ha sviluppato i contenuti affidabili di Bookimed, con il supporto di un Master in filologia e interviste con esperti medici da tutto il mondo.
Revisione da parte di Consulente medico Bookimed
Fahad Mawlood
Editor medico e Data Scientist
Medico generico. Vincitore di 4 premi scientifici. Ha lavorato in Asia Occidentale. Ex capo del team medico per i pazienti di lingua araba. Ora responsabile dell'elaborazione dei dati e dell'accuratezza dei contenuti medici.
Fahad Mawlood Linkedin
Questa pagina può includere informazioni relative a varie condizioni mediche, trattamenti e servizi sanitari disponibili in diversi paesi. Si prega di notare che il contenuto è fornito solo a scopo informativo e non deve essere interpretato come consiglio o indicazione medica. Si prega di consultare il proprio medico o un professionista sanitario qualificato prima di iniziare o modificare un trattamento medico.

Domande frequenti sul trattamento di Glioma in Italia

Queste domande frequenti provengono da pazienti reali che cercano assistenza medica tramite Bookimed. Le risposte sono fornite da coordinatori medici esperti e rappresentanti affidabili delle cliniche.

What key molecular markers do Italian clinics test to guide glioma therapy?

Italian clinics use molecular markers like IDH1/2 mutations, 1p/19q co-deletion, and MGMT promoter methylation to guide glioma therapy. These genetic indicators follow the World Health Organization standards. They help specialists determine if a patient requires radiotherapy, specific chemotherapies, or targeted clinical trials.

  • IDH1/2 mutations: Distinguish astrocytomas from glioblastomas in 92% of Italian cases.
  • MGMT methylation: Predicts high tumor sensitivity to temozolomide chemotherapy for glioblastoma.
  • 1p/19q co-deletion: Defines oligodendroglioma and directs the use of PCV chemotherapy.
  • CDKN2A/B deletion: Acts as a marker for aggressive WHO Grade 4 tumors.

Bookimed Expert Insight: Italian centers with IRCCS accreditation, such as San Raffaele in Milan, function as research-intensive hospitals. These facilities integrate molecular profiling directly into clinical practice more rapidly than regional clinics. For example, San Raffaele performs over 52,000 operations annually. This high volume often allows for faster access to advanced panels like BRAF and NTRK. These tests are essential for matching patients with targeted therapy trials.

Patient Consensus: Patients emphasize the importance of requesting the full molecular pathology report rather than just the surgical summary. They note that Italian doctors use the combination of histology and markers to build the final treatment plan.

Which surgical technologies help Italian neurosurgeons maximize tumor removal while protecting brain function?

Italian neurosurgeons utilize integrated intraoperative ecosystems to maximize glioma resection while preserving eloquent brain regions. Key technologies include intraoperative ultrasound for real-time tracking of brain shift and 5-ALA fluorescence-guided surgery. These tools differentiate tumor margins from healthy tissue in specialized Scientific Institutes for Research, Hospitalization and Health Care (IRCCS) facilities.

  • Intraoperative imaging: Contrast-enhanced ultrasound and intraoperative MRI provide live feedback on residual tumor margins.
  • Awake craniotomy: Direct electrical stimulation allows real-time monitoring of speech and motor functions.
  • Fluorescence guidance: 5-aminolevulinic acid (5-ALA) makes high-grade glioma cells glow under specialized blue-light microscopes.
  • Connectomics mapping: Diffusion Tensor Imaging (DTI) tractography helps surgeons plan trajectories around critical white matter.

Bookimed Expert Insight: Italian centers like San Raffaele demonstrate that high-volume research hospitals often combine academic innovation with practical safety. While many facilities offer craniotomies, those performing over 52,000 operations annually typically provide more refined intraoperative neuromonitoring setups. This volume often correlates with higher proficiency in using specialized imaging like intraoperative ultrasound repeatedly during a single case.

Patient Consensus: Patients note that awake mapping provides significant peace of mind when tumors are near speech centers. Many emphasize that using intraoperative ultrasound or 5-ALA helped them feel more confident about the thoroughness of the surgery.

What is the standard first-line treatment protocol for high-grade gliomas in Italy?

Standard first-line treatment for high-grade gliomas in Italy follows the international Stupp protocol. This integrated approach combines maximal safe surgical resection with concurrent radiotherapy and temozolomide chemotherapy. Treatment decisions depend on molecular markers like MGMT methylation and IDH mutation status to optimize outcomes.

  • Surgical resection: Neurosurgeons perform craniotomy to remove the maximum tumor volume safely.
  • Radiotherapy phase: Patients receive 60 Gy in 30 sessions over 6 weeks.
  • Concurrent chemotherapy: Daily temozolomide is administered alongside radiation to sensitize tumor cells.
  • Adjuvant phase: Patients continue 6 to 12 cycles of higher-dose maintenance chemotherapy.

Bookimed Expert Insight: Italian research hospitals like San Raffaele hold IRCCS accreditation from the Ministry of Health. This status confirms they integrate clinical care with advanced medical research. These centers perform over 52,000 operations yearly and often provide earlier access to diagnostic molecular profiling. Specialist teams use this data to adjust treatment intensity for patients based on age.

Patient Consensus: Patients note that multidisciplinary teams, rather than single doctors, coordinate the complex care steps. Many emphasize the need to schedule pathology reviews and follow-up imaging quickly to avoid treatment delays.

Are novel or experimental glioblastoma therapies currently available in Italy?

Italy offers several novel glioblastoma therapies through specialized research hospitals known as IRCCS. Patients can access targeted treatments like Regorafenib for recurrence. Clinical trials investigate gene therapies and focused ultrasound for blood-brain barrier disruption. These protocols are primarily available at major hubs in Milan and Bologna.

  • Targeted therapy: Regorafenib is an approved second-line treatment for relapsed glioblastoma.
  • Particle therapy: Hadrontherapy using carbon ions is available for radio-resistant brain tumors.
  • Electric fields: Tumor Treating Fields (TTFields) use wearable technology to disrupt cancer cells.
  • Gene therapy: Early-phase trials in Milan evaluate modified cells delivering interferon-alpha2.

Bookimed Expert Insight: Milan serves as Italy's primary hub for experimental neuro-oncology. San Raffaele performs 52,000 operations annually and conducts high-level research as an IRCCS-accredited facility. Choosing a center with this accreditation is vital. These institutions receive state funding specifically to bridge the gap between laboratory research and patient bedside care.

Patient Consensus: Patients note that access to experimental treatments depends heavily on early molecular profiling. They emphasize that while innovative options exist, they are often restricted to select academic centers and require strict eligibility for trial enrollment.

Can EU/EEA citizens receive subsidized glioma treatment in Italy?

EU/EEA citizens can access subsidized glioma treatment in Italy through the Italian National Health Service (SSN). Coverage depends on using the S2 form for planned care or the European Health Insurance Card (EHIC) for medically necessary emergency treatment. Specialized centers like San Raffaele provide comprehensive neuro-oncology services under these frameworks.

  • S2 Route: Requires prior authorization from your home country for direct coverage in Italy.
  • EHIC Access: Covers urgent or necessary oncology care during temporary stays in Italy.
  • Ticket System: Patients pay a minor co-payment for diagnostics unless they have pathology exemptions.
  • Service Scope: Subsidies apply only to public hospitals and IRCCS-accredited research facilities.

Bookimed Expert Insight: While Italy offers subsidies, the regionalized nature of their healthcare system means care quality varies. Major research hospitals like San Raffaele in Milan perform over 52,000 operations annually and hold IRCCS accreditation from the Italian Ministry of Health. Patients seeking complex glioma resection should target these high-volume centers in Lombardy. These institutions typically manage the largest volume of neuro-oncology cases nationwide.

Patient Consensus: Patients note that while EU citizenship is a baseline, having the correct S2 or EHIC paperwork is the only way to avoid high private costs. Many emphasize choosing high-volume centers in northern Italy, even if it requires more travel logistics than local public options.

How is post-surgical care coordinated in Italian glioma centers?

Italian glioma centers coordinate post-surgical care through a centralized Multidisciplinary Tumor Board model within specialized research hospitals. This network integrates neurosurgery, oncology, and rehabilitation. Specialized units ensure seamless transitions from surgery to adjuvant treatments like the Stupp Protocol or Gamma Knife radiosurgery.

  • Tumor board review: Specialists review MRI and molecular profiles weekly to determine treatment.
  • Adjuvant timeline: Radiation and chemotherapy typically begin 2 to 4 weeks post-surgery.
  • Integrated rehabilitation: Early assessments map cognitive and motor functions for tailored physical therapy.
  • Follow-up surveillance: Scheduled neurosurgical and radiological evaluations monitor recovery every 4 to 8 weeks.

Bookimed Expert Insight: While many seek the largest city hospitals, data shows that IRCCS-accredited centers like San Raffaele or San Donato Hospital offer superior coordination. These facilities manage over 300,000 patients annually and house surgery, imaging, and pathology under one roof. This internal proximity often reduces the common 2-week bottleneck for integrated pathology reports.

Patient Consensus: Patients note that care is smoothest when all departments are in the same building. They recommend keeping personal copies of MRI discs and pathology reports to ensure seamless handoffs between specialists.

Richiedi una consulenza gratuita

Seleziona il modo migliore per essere contattato